Guggenheim Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Buy
172,280
+15,741
+10% +$1.38M 0.1% 191
2026
Q1
$13.3M Sell
156,539
-955
-0.6% -$85.1K 0.1% 211
2025
Q4
$12.4M Buy
157,494
+10,558
+7% +$828K 0.09% 233
2025
Q3
$11.7M Buy
146,936
+20,664
+16% +$1.76M 0.09% 237
2025
Q2
$11.5M Sell
126,272
-1,917
-1% -$175K 0.09% 225
2025
Q1
$12M Sell
128,189
-3,610
-3% -$323K 0.11% 193
2024
Q4
$12M Buy
131,799
+3,559
+3% +$340K 0.1% 213
2024
Q3
$13.3M Sell
128,240
-20,825
-14% -$2.12M 0.09% 226
2024
Q2
$14.5M Buy
149,065
+24,181
+19% +$2.23M 0.1% 204
2024
Q1
$11.2M Sell
124,884
-16,527
-12% -$1.4M 0.08% 286
2023
Q4
$11.3M Buy
141,411
+7,484
+6% +$563K 0.09% 276
2023
Q3
$9.52M Sell
133,927
-22,684
-14% -$1.7M 0.08% 290
2023
Q2
$12.1M Sell
156,611
-8,791
-5% -$680K 0.09% 228
2023
Q1
$12.4M Buy
165,402
+30,193
+22% +$2.25M 0.1% 220
2022
Q4
$10.7M Sell
135,209
-31,673
-19% -$2.37M 0.09% 268
2022
Q3
$11.7M Buy
166,882
+60,139
+56% +$4.72M 0.11% 227
2022
Q2
$8.55M Sell
106,743
-10,227
-9% -$800K 0.07% 351
2022
Q1
$8.87M Buy
116,970
+4,881
+4% +$387K 0.05% 431
2021
Q4
$9.57M Sell
112,089
-37,527
-25% -$2.93M 0.05% 446
2021
Q3
$11.3M Sell
149,616
-12,930
-8% -$1.03M 0.07% 341
2021
Q2
$13.2M Sell
162,546
-64,339
-28% -$5.26M 0.08% 302
2021
Q1
$17.9M Sell
226,885
-18,539
-8% -$1.45M 0.12% 193
2020
Q4
$21M Sell
245,424
-53,058
-18% -$4.39M 0.13% 133
2020
Q3
$23M Sell
298,482
-59,166
-17% -$4.51M 0.17% 107
2020
Q2
$26.2M Buy
357,648
+3,067
+0.9% +$218K 0.2% 89
2020
Q1
$23.5M Sell
354,581
-26,171
-7% -$1.85M 0.24% 83
2019
Q4
$26.2M Sell
380,752
-52,371
-12% -$3.57M 0.2% 103
2019
Q3
$31.8M Buy
433,123
+7,751
+2% +$562K 0.25% 71
2019
Q2
$30.5M Sell
425,372
-22,987
-5% -$1.63M 0.25% 69
2019
Q1
$30.7M Buy
448,359
+78,731
+21% +$5.09M 0.25% 63
2018
Q4
$22M Buy
369,628
+54,687
+17% +$3.42M 0.19% 90
2018
Q3
$21.1M Buy
314,941
+15,995
+5% +$1.07M 0.14% 130
2018
Q2
$19.4M Sell
298,946
-576,016
-66% -$37.7M 0.13% 149
2018
Q1
$62.7M Sell
874,962
-18,490
-2% -$1.33M 0.15% 191
2017
Q4
$67.4M Buy
893,452
+17,315
+2% +$1.26M 0.16% 176
2017
Q3
$63.8M Buy
876,137
+3,802
+0.4% +$274K 0.15% 156
2017
Q2
$64.7M Sell
872,335
-13,284
-1% -$986K 0.17% 146
2017
Q1
$64.8M Sell
885,619
-180,155
-17% -$12.6M 0.18% 123
2016
Q4
$69.7M Sell
1,065,774
-32,232
-3% -$2.21M 0.2% 71
2016
Q3
$81.4M Sell
1,098,006
-114,074
-9% -$8.43M 0.25% 41
2016
Q2
$88.7M Buy
1,212,080
+200,532
+20% +$14.3M 0.28% 33
2016
Q1
$71.5M Buy
1,011,548
+85,283
+9% +$5.67M 0.23% 58
2015
Q4
$61.7M Sell
926,265
-92,835
-9% -$6.18M 0.18% 109
2015
Q3
$64.7M Buy
1,019,100
+211,049
+26% +$13.8M 0.2% 76
2015
Q2
$52.9M Buy
808,051
+32,345
+4% +$2.19M 0.13% 198
2015
Q1
$53.8M Buy
775,706
+63,233
+9% +$4.37M 0.13% 202
2014
Q4
$49.3M Buy
712,473
+55,097
+8% +$3.72M 0.12% 235
2014
Q3
$42.9M Buy
657,376
+35,278
+6% +$2.33M 0.1% 270
2014
Q2
$42.4M Buy
622,098
+43,891
+8% +$2.94M 0.11% 271
2014
Q1
$37.5M Sell
578,207
-7,571
-1% -$477K 0.11% 264
2013
Q4
$38.2M Buy
585,778
+64,227
+12% +$4.11M 0.12% 214
2013
Q3
$30.9M Buy
521,551
+38,413
+8% +$2.28M 0.11% 222
2013
Q2
$27.7M Buy
+483,138
New +$28.7M 0.12% 192

Other funds holding CL

Guggenheim Capital's CL Position: Q2 2026 in Review

Guggenheim Capital increased its Colgate-Palmolive (CL) stake by 10% in Q2 2026, buying an estimated $1.38M and bringing the position to 172,280 shares worth $15.8M. The position accounts for 0.1% of the portfolio, ranked #191.

Guggenheim Capital first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $88.7M in Q2 2016. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Guggenheim Capital held 172,280 shares of Colgate-Palmolive worth $15.8M as of Q2 2026.
  • Guggenheim Capital bought 15,741 Colgate-Palmolive shares in Q2 2026, an estimated $1.38M.
  • Colgate-Palmolive made up 0.1% of Guggenheim Capital's portfolio in Q2 2026, its #191 holding.
  • Guggenheim Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Guggenheim Capital's Colgate-Palmolive position peaked at $88.7M in Q2 2016.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.